Production of 6-[18F]fluoro-l-DOPA and its metabolism in vivo—a critical review

https://doi.org/10.1016/0883-2897(92)90002-GGet rights and content

Abstract

This report critically appraises methods for the synthesis of 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine (6-FDOPA) that are based on labelling by non-regioselective electrophilic fluorination, regioselective fluorodemetalation or nucleophilic substitution. Recommendations for the standardization of labelling procedures, the optimization of radiochemical yield and the assurance of product quality and safety are given. Studies of the metabolism of 6-FDOPA in vivo are also reviewed to emphasize the importance of the biochemical component of the development of this tracer for positron emission tomography (PET).

References (70)

  • G. Firnau et al.

    [18F]Fluoro-l-Dopa for the in vivo study of intracerebral dopamine

    Appl. Radiat. Isot.

    (1986)
  • J.R. Grierson et al.

    In-situ preparation of a chemically bonded chiral stationary phase for the separation of aromatic α-amino enantiomers

    J. Chromatogr.

    (1985)
  • M. Guillaume et al.

    Recommendations for fluorine-18 production

    Appl. Radiat. Isot.

    (1991)
  • C. Lemaire et al.

    An approach to the asymmetric synthesis of 6-[18F]fluoro-l-dopa via NCA nucleiphilic fluorination

    Appl. Radiat. Isot.

    (1991)
  • A. Luxen et al.

    Fluorination of substituted veratroles via regioselective mercuration

    Tetrahed. Lett.

    (1988)
  • A. Luxen et al.

    Remote, semiautomated production of 6-[18F]fluoro-l-dopa for human studies with PET

    Appl. Radiat. Isot.

    (1990)
  • W.P. Melega et al.

    Comparative in-vivo metabolism of 6-[18F]fluoro-l-dopa and [3H]l-dopa in rats

    Biochem. Pharmacol.

    (1990)
  • W.P. Melega et al.

    The effects of carbidopa on the metabolism of 6-[18F]fluoro-l-DOPA in rats, monkeys and humans

    Life Sci.

    (1990)
  • C. Nahmias et al.

    Striatal dopamine distribution in parkinsonian patients during life

    J. Neurolog. Sci.

    (1985)
  • V.W. Pike et al.

    Labelled agents for PET studies of the dopaminergic system-some quality assurance methods, experience and issues

    Appl. Radiat. Isot.

    (1990)
  • C. Sachs et al.

    Selective 6-hydroxy-DOPA induced degeneration of central and peripheral noradrenalin neurons

    Brain Res.

    (1972)
  • M.J. Adam et al.

    Routine synthesis of l-[18F]6-fluorodopa with fluorine-18 acetylhypofluorite

    J. Nucl. Med.

    (1986)
  • G. Antoni et al.

    Asymetric synthesis of l-[3-11C]alanine

    Acta Chem. Scand. B

    (1987)
  • J.R. Barrio et al.

    In vivo assessment of neurotransmitter biochemistry in humans

    Annu. Rev. Pharmacol. Toxicol.

    (1988)
  • G.T. Bida et al.

    The synthesis of 2-[18F]fluoro-2-deoxy-d-glucose using glycals: a reexamination

    J. Nucl. Med.

    (1984)
  • D.B. Calne et al.

    Positron emission tomography after MPTP: observation relating to the cause of Parkinson's disease

    Nature

    (1985)
  • V. Casella et al.

    Anhydrous F-18 labeled elemental fluorine for radiopharmaceutical preparation

    J. Nucl. Med.

    (1980)
  • T. Chaly et al.

    High yield synthesis of 6-[18F]fluoro-l-Dopa by regioselective fluorination of protected l-Dopa with [18F]acetylhypofluorite

    J. Nucl. Med.

    (1986)
  • J-J. Chen et al.

    Quality control procedure for 6-[18F]fluoro-l-dopa; a presynaptic PET imaging ligand for brain dopamine neurons

    J. Nucl. Med.

    (1989)
  • R. Chirakal et al.

    High yield synthesis of 6-[18F]fluoro-l-dopa

    J. Nucl. Med.

    (1986)
  • T.W. Clarkson et al.

    Atomic adsorption determination of total, inorganic and organic mercury in biological fluids

  • P. Cumming et al.

    The metabolism of [18F]-6-fluoro-l-3,4-dihydroxyphenylalamine in the hooded rat

    J. Neurochem.

    (1987)
  • B.B. Dunn et al.

    A single column, rapid quality control procedure for 6-[18F]fluoro-l-DOPA and 6-[18F]fluorodopamine PET imaging agents

    J. Labelled Cmpd. Radiopharm.

    (1991)
  • M. Diksic et al.

    New synthesis of fluorine-18 labelled 6-fluoro-l-Dopa by cleaving the carbon-silicon bond with fluorine

    J. Nucl. Med.

    (1985)
  • G. Firnau et al.

    Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-l-dopa

    J. Nucl. Med.

    (1984)
  • Cited by (98)

    • Synthesis of 6-[<sup>11</sup>C]methyl-m-tyrosine ([<sup>11</sup>C]6MemTyr) for dopamine synthesis imaging in living brain using PET

      2015, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      A further limitation is due to the radiolabeling production of [18F]FDOPA. The electrophilic reactions using molecular [18F]F2 or [18F]acetylhypofluorite provide low radiochemical yields of [18F]FDOPA with very low specific radioactivity.6 Although, in addition to the electrophilic reactions, nucleophilic reactions with no-carrier-added [18F]fluoride was also developed for [18F]FDOPA synthesis, there are concerns about the complex multistep reactions with a long production time and enantiomeric purity.7,8

    • <sup>18</sup>F-DOPA PET/computed tomography imaging

      2014, PET Clinics
      Citation Excerpt :

      18F-DOPA is a large neutral amino acid that resembles natural l-dopa biochemically and presents similar kinetics. It enters the catecholamine metabolic pathway of endogenous l-DOPA both in the brain and peripherally.9,10 The relatively long half-life (110 minutes) of 18F-DOPA makes it suitable for transportation even in centers with no cyclotron facility on site, allows more flexible imaging timings, and offers the possibility for late images, which are very important in some cases.

    • Molecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications, Second Edition

      2023, Molecular Imaging and Targeted Therapy: Radiopharmaceuticals and Clinical Applications, Second Edition
    View all citing articles on Scopus

    A report from a task group organised within the framework of the EEC concerted action on “PET investigations of cellular regeneration and degeneration”.

    View full text